10
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Topical glucocorticoids

How they are used and misused

Pages 283-291 | Published online: 16 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Edith N Nnoruka, Olaniyi OM Daramola & Samuel O Ike. (2007) Misuse and abuse of topical steroids: implications. Expert Review of Dermatology 2:1, pages 31-40.
Read now

Articles from other publishers (6)

Ulrich R. Hengge. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology 815 830 .
Ahmad Nofal & Eman Salah. (2013) Acquired poikiloderma: Proposed classification and diagnostic approach. Journal of the American Academy of Dermatology 69:3, pages e129-e140.
Crossref
Ulrich R. Hengge. 2008. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology 561 577 .
Ulrich R. Hengge, Thomas Ruzicka, Robert A. Schwartz & Michael J. Cork. (2006) Adverse effects of topical glucocorticosteroids. Journal of the American Academy of Dermatology 54:1, pages 1-15.
Crossref
Marsha L. Gordon. (1998) The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses. Clinical Therapeutics 20:1, pages 26-39.
Crossref
H. Irving Katz. (1995) Topical Corticosteroids. Dermatologic Clinics 13:4, pages 805-815.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.